0
0
10/13/23 at 9:47pm
Organization
CNBC
Author
Jacob Pramuk
37 words
0
Comments
Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected.
You are the first to view
https://www.cnbc.com/2023/10/13/pfizer-cuts-earnings-revenue-guidance-as-covid-sales-slump.html
Create an account
or login to join the discussion